BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 2392131)

  • 1. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
    Medina I; Mills J; Leoung G; Hopewell PC; Lee B; Modin G; Benowitz N; Wofsy CB
    N Engl J Med; 1990 Sep; 323(12):776-82. PubMed ID: 2392131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.
    Safrin S; Finkelstein DM; Feinberg J; Frame P; Simpson G; Wu A; Cheung T; Soeiro R; Hojczyk P; Black JR
    Ann Intern Med; 1996 May; 124(9):792-802. PubMed ID: 8610948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ; Hauptman SP
    Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
    Leoung GS; Mills J; Hopewell PC; Hughes W; Wofsy C
    Ann Intern Med; 1986 Jul; 105(1):45-8. PubMed ID: 2940954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
    Bozzette SA; Finkelstein DM; Spector SA; Frame P; Powderly WG; He W; Phillips L; Craven D; van der Horst C; Feinberg J
    N Engl J Med; 1995 Mar; 332(11):693-9. PubMed ID: 7854375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions.
    Lee BL; Medina I; Benowitz NL; Jacob P; Wofsy CB; Mills J
    Ann Intern Med; 1989 Apr; 110(8):606-11. PubMed ID: 2784648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study.
    Sattler FR; Cowan R; Nielsen DM; Ruskin J
    Ann Intern Med; 1988 Aug; 109(4):280-7. PubMed ID: 3260759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial.
    Wharton JM; Coleman DL; Wofsy CB; Luce JM; Blumenfeld W; Hadley WK; Ingram-Drake L; Volberding PA; Hopewell PC
    Ann Intern Med; 1986 Jul; 105(1):37-44. PubMed ID: 3521428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonitis in patients with acquired immunodeficiency syndrome.
    Wofsy CB
    Rev Infect Dis; 1987; 9 Suppl 2():S184-94. PubMed ID: 3554457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.
    Martin MA; Cox PH; Beck K; Styer CM; Beall GN
    Arch Intern Med; 1992 Mar; 152(3):523-8. PubMed ID: 1546914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.
    Hughes W; Leoung G; Kramer F; Bozzette SA; Safrin S; Frame P; Clumeck N; Masur H; Lancaster D; Chan C
    N Engl J Med; 1993 May; 328(21):1521-7. PubMed ID: 8479489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapsone treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
    Mills J; Leoung G; Medina I; Hopewell PC; Hughes WT; Wofsy C
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1057-60. PubMed ID: 3263834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumocystis carinii pneumonia: therapy and prophylaxis.
    Kovacs JA; Masur H
    J Infect Dis; 1988 Jul; 158(1):254-9. PubMed ID: 2969023
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
    Small CB; Harris CA; Friedland GH; Klein RS
    Arch Intern Med; 1985 May; 145(5):837-40. PubMed ID: 3873229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful treatment of HIV-associated pneumocystis carinii pneumonia with dapsone plus trimethoprim].
    Rüttimann S; Laifer G
    Wien Klin Wochenschr; 1992; 104(18):570-3. PubMed ID: 1413818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome.
    Gordin FM; Simon GL; Wofsy CB; Mills J
    Ann Intern Med; 1984 Apr; 100(4):495-9. PubMed ID: 6230976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentamidine aerosol versus trimethoprim-sulfamethoxazole for Pneumocystis carinii in acquired immune deficiency syndrome.
    Montgomery AB; Feigal DW; Sattler F; Mason GR; Catanzaro A; Edison R; Markowitz N; Johnson E; Ogawa S; Rovzar M
    Am J Respir Crit Care Med; 1995 Apr; 151(4):1068-74. PubMed ID: 7697233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
    El-Sadr WM; Murphy RL; Yurik TM; Luskin-Hawk R; Cheung TW; Balfour HH; Eng R; Hooton TM; Kerkering TM; Schutz M; van der Horst C; Hafner R
    N Engl J Med; 1998 Dec; 339(26):1889-95. PubMed ID: 9862944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Bucher HC; Griffith L; Guyatt GH; Opravil M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):104-14. PubMed ID: 9241108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
    Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
    Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.